389 related articles for article (PubMed ID: 34935436)
21. Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reaction.
Tsetsarkin KA; McGee CE; Higgs S
Virol J; 2011 Jul; 8():376. PubMed ID: 21801412
[TBL] [Abstract][Full Text] [Related]
22. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
[TBL] [Abstract][Full Text] [Related]
23. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
[TBL] [Abstract][Full Text] [Related]
24. Two novel epistatic mutations (E1:K211E and E2:V264A) in structural proteins of Chikungunya virus enhance fitness in Aedes aegypti.
Agarwal A; Sharma AK; Sukumaran D; Parida M; Dash PK
Virology; 2016 Oct; 497():59-68. PubMed ID: 27423270
[TBL] [Abstract][Full Text] [Related]
25. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
26. Importance of mosquito "quasispecies" in selecting an epidemic arthropod-borne virus.
Vazeille M; Zouache K; Vega-Rúa A; Thiberge JM; Caro V; Yébakima A; Mousson L; Piorkowski G; Dauga C; Vaney MC; Manni M; Gasperi G; de Lamballerie X; Failloux AB
Sci Rep; 2016 Jul; 6():29564. PubMed ID: 27383735
[TBL] [Abstract][Full Text] [Related]
27. A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.
Selvarajah S; Sexton NR; Kahle KM; Fong RH; Mattia KA; Gardner J; Lu K; Liss NM; Salvador B; Tucker DF; Barnes T; Mabila M; Zhou X; Rossini G; Rucker JB; Sanders DA; Suhrbier A; Sambri V; Michault A; Muench MO; Doranz BJ; Simmons G
PLoS Negl Trop Dis; 2013; 7(9):e2423. PubMed ID: 24069479
[TBL] [Abstract][Full Text] [Related]
28. Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion.
van Duijl-Richter MK; Hoornweg TE; Rodenhuis-Zybert IA; Smit JM
Viruses; 2015 Jul; 7(7):3647-74. PubMed ID: 26198242
[TBL] [Abstract][Full Text] [Related]
29. Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
Chua CL; Sam IC; Merits A; Chan YF
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004960. PubMed ID: 27571254
[TBL] [Abstract][Full Text] [Related]
30. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
[TBL] [Abstract][Full Text] [Related]
31. Acidic pH-Induced Conformational Changes in Chikungunya Virus Fusion Protein E1: a Spring-Twisted Region in the Domain I-III Linker Acts as a Hinge Point for Swiveling Motion of Domains.
Sahoo B; Gudigamolla NK; Chowdary TK
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938768
[TBL] [Abstract][Full Text] [Related]
32. Dissemination and transmission of the E1-226V variant of chikungunya virus in Aedes albopictus are controlled at the midgut barrier level.
Arias-Goeta C; Mousson L; Rougeon F; Failloux AB
PLoS One; 2013; 8(2):e57548. PubMed ID: 23437397
[TBL] [Abstract][Full Text] [Related]
33. Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes.
Göertz GP; Lingemann M; Geertsema C; Abma-Henkens MHC; Vogels CBF; Koenraadt CJM; van Oers MM; Pijlman GP
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006958. PubMed ID: 30412583
[TBL] [Abstract][Full Text] [Related]
34. Identification of Functional Determinants in the Chikungunya Virus E2 Protein.
Weber C; Berberich E; von Rhein C; Henß L; Hildt E; Schnierle BS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005318. PubMed ID: 28114368
[TBL] [Abstract][Full Text] [Related]
35. Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes.
Tsetsarkin KA; McGee CE; Volk SM; Vanlandingham DL; Weaver SC; Higgs S
PLoS One; 2009 Aug; 4(8):e6835. PubMed ID: 19718263
[TBL] [Abstract][Full Text] [Related]
36. Conformational changes in Chikungunya virus E2 protein upon heparan sulfate receptor binding explain mechanism of E2-E1 dissociation during viral entry.
Sahoo B; Chowdary TK
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31167876
[TBL] [Abstract][Full Text] [Related]
37. Chikungunya virus and its mosquito vectors.
Higgs S; Vanlandingham D
Vector Borne Zoonotic Dis; 2015 Apr; 15(4):231-40. PubMed ID: 25674945
[TBL] [Abstract][Full Text] [Related]
38. Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries.
Khongwichit S; Chansaenroj J; Chirathaworn C; Poovorawan Y
J Biomed Sci; 2021 Dec; 28(1):84. PubMed ID: 34857000
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of Getah Virus by a Single Amino Acid Substitution at Residue 253 of the E2 Protein that Might Be Part of a New Heparan Sulfate Binding Site on Alphaviruses.
Wang N; Zhai X; Li X; Wang Y; He WT; Jiang Z; Veit M; Su S
J Virol; 2022 Mar; 96(6):e0175121. PubMed ID: 34986000
[TBL] [Abstract][Full Text] [Related]
40. pH-dependent entry of chikungunya virus into Aedes albopictus cells.
Gay B; Bernard E; Solignat M; Chazal N; Devaux C; Briant L
Infect Genet Evol; 2012 Aug; 12(6):1275-81. PubMed ID: 22386853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
